Join us in Boston, Massachusetts, USA, from July 12–14, 2027, for the 4th Global Cell & Gene Therapy Summit 2027, where leading scientists, clinicians, researchers, biotechnology innovators, regulatory experts, and industry pioneers will gather to shape the future of advanced therapies.
The summit serves as a premier international platform dedicated to showcasing the latest breakthroughs in cell therapy, gene therapy, regenerative medicine, genome editing, viral vector technologies, manufacturing, quality, regulatory science, clinical translation, commercialization, and patient access. We warmly invite researchers, healthcare professionals, academic institutions, biotechnology and pharmaceutical companies, investors, sponsors, exhibitors, and delegates from around the world to participate in this transformative event.
Read MoreCGT-2027 is dedicated to bridging the gap between academia and industry, facilitating partnerships that accelerate research and development in Cell and Gene Therapy.
Connect with leading researchers, industry experts, and decision-makers to explore collaborations, funding opportunities, and strategic partnerships.
Gain insights into the latest discoveries and advancements in Cell and Gene Therapy through keynote presentations, panel discussions, and interactive sessions.
Learn how academic research can translate into practical applications that impact the industry, paving the way for transformative therapies and treatments.
• Group discounts available for 3+ delegates — contact us
A comprehensive program featuring keynote addresses, scientific sessions, workshops, poster presentations, and networking events.
The CGT Summit has welcomed a diverse range of exhibitors, from global industry leaders to emerging innovators. By showcasing breakthrough technologies, services, and solutions, our past exhibitors have played a key role in advancing the cell and gene therapy field and shaping meaningful collaborations within the community.
Interested in becoming a sponsor or exhibitor at CGT-2027?
Become a SponsorRelive the energy, innovation, and collaboration from past CGT summits.
Hear from the world's leading researchers, clinicians, and industry professionals who attended past summits.
Our dedicated team is ready to assist with registration, sponsorship, abstract submission, and logistics.
Latest Updates
Stay connected with the latest news and announcements from the CGT community.
What separates successful advanced therapy programs from the rest? That was the focus of Mark Leney's presentation at the Cell & Gene Therapy Summit this week. ⬇️ Read Mark's reflections from the event. #CellAndGeneTherapy #AdvancedTherapies #Biotech #DrugD...
The 3rd #CGTSummit2026 kicked off today in Boston and Minaris is a Supporting Sponsor. Heather Durant and Emmanuelle Bommier are on site and ready to connect with innovators and therapy developers who are advancing the next generation of cell and gene thera...
This week, Víctor Manuel Díaz Cortés, Head of Research at #OneChain Immunotherapeutics, spoke at the 3rd Global Cell & Gene Therapy Summit (#cgtsummit2026) in Boston, MA. As part of Session IV: Cell Therapy Manufacturing, AI and Process Innovation, Víctor pr...
Just wrapped moderating an insightful panel on "Creating a Commercially Viable Therapy" at the 3rd Global Cell & Gene Therapy Summit in Boston. 🎤 A candid conversation with Vaishali Shukla, PhD (Eli Lilly), Jennifer MacDonald, MD (ARMI), Ryan Murray, PhD (Ki...
Excited to welcome Jennifer MacDonald, MD, and ARMI | BioFabUSA to CGTSummit2026. Looking forward to valuable insights on bridging innovation, manufacturing, and commercialization to bring advanced therapies to patients. 🚀🧬
If turnaround time and volume of samples are the bottle necks, Stop by our booth and attend the talk to know more how #nextgenerationsequencing gets implemented into your #viralsafety #adventitiousagent screen for #qualitycontrol #biomanufacturing
Goodbye San Diego, Hello Boston! Looking forward to joining the 3rd Global Cell & Gene Therapy Summit. Come fully caffeinated for my keynote on AI-Driven Decision Making for Genomic Medicine Development and Manufacturing! I’ll share how we’re using REAL inte...